Paul Singer - Elliott Investment Management
Holding/activity history for BioMarin Pharmaceutical Inc. (BMRN)
← All BMRN superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q2 | 0 | 0.00 | Sell 100.00% | 2.27 | $52.93–70.63 · VW $59.44i | SEC | |
| 2025 Q1 | 3,500,338 | 2.27 | $70.69 | $247,438,893 | SEC | ||
| 2024 Q4 | 3,500,338 | 2.54 | $65.73 | $230,077,217 | SEC | ||
| 2024 Q3 | 3,500,338 | 2.36 | $70.29 | $246,038,758 | SEC | ||
| 2024 Q2 | 3,500,338 | 1.71 | $82.33 | $288,182,828 | SEC | ||
| 2024 Q1 | 3,500,338 | 2.18 | Add 16.66% | 0.31 | $83.44–99.25 · VW $88.92i | $305,719,521 | SEC |
| 2023 Q4 | 3,000,338 | 3.50 | Buy | 3.50 | $76.02–99.56 · VW $88.45i | $289,292,590 | SEC |
Price snapshot:
Current price$59.20
52-week low$49.26
52-week high$66.28